Anika Therapeutics reported $276.66M in Equity Capital and Reserves for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 810.83M 44.28M
Acorda Therapeutics ACOR:US $ 206.28M 31.68M
Adamas Pharmaceuticals ADMS:US -49976000 15.36M
Agenus AGEN:US $ -167.06M 9.69M
Agios Pharmaceuticals AGIO:US $ 2296.63M 1897.13M
Anika Therapeutics ANIK:US $ 276.66M 4.26M
Arrowhead Research ARWR:US $ 445.55M 8.92M
Chemocentryx CCXI:US $ 361M 24.61M
Clovis Oncology CLVS:US $ -221.04M 62.29M
Dicerna Pharmaceuticals DRNA:US $ 126.4M 11.35M
Enanta Pharmaceuticals ENTA:US $ 436.03M 15.96M
Halozyme Therapeutics HALO:US $ 151.05M 52.06M
Heron Therapeutics HRTX:US $ 196.22M 40.27M
Insmed INSM:US $ 201.64M 74.25M
Integra Lifesciences IART:US $ 1529.33M 14.46M
Johnson & Johnson JNJ:US $ 65834M 2556M
Karyopharm Therapeutics KPTI:US $ -39640000 90.19M
Ligand Pharmaceuticals LGND:US $ 745.84M 36.32M
Macrogenics MGNX:US $ 350.53M 54.65M
Merit Medical Systems MMSI:US $ 976.69M 18.12M
Rigel Pharmaceuticals RIGL:US $ 78.3M 44.27M
Sangamo Biosciences SGMO:US $ 470.36M 27.88M
Stryker SYK:US $ 13502M 418M
Surmodics SRDX:US $ 142.08M 8.67M
Veracyte VCYT:US $ 421.23M 1.49M
Xencor XNCR:US $ 583.61M 11.17M